# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-25-020157
Filing Date
2025-05-22
Accepted
2025-05-22 16:01:49
Documents
43
Period of Report
2025-05-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20048898_8k.htm iXBRL | 8-K | 44256
2 | EXHIBIT 99.1 | ef20048898_ex99-1.htm | EX-99.1 | 30802
3 | EXHIBIT 99.2 | ef20048898_ex99-2.htm | EX-99.2 | 64761
7 |  | ef20048898_ex99-2slide1.jpg | GRAPHIC | 81966
8 | GRAPHIC | ef20048898_ex99-2slide2.jpg | GRAPHIC | 352989
9 | GRAPHIC | ef20048898_ex99-2slide3.jpg | GRAPHIC | 163715
10 | GRAPHIC | ef20048898_ex99-2slide4.jpg | GRAPHIC | 178917
11 | GRAPHIC | ef20048898_ex99-2slide5.jpg | GRAPHIC | 142901
12 | GRAPHIC | ef20048898_ex99-2slide6.jpg | GRAPHIC | 130745
13 | GRAPHIC | ef20048898_ex99-2slide7.jpg | GRAPHIC | 99210
14 | GRAPHIC | ef20048898_ex99-2slide8.jpg | GRAPHIC | 112515
15 | GRAPHIC | ef20048898_ex99-2slide9.jpg | GRAPHIC | 108749
16 | GRAPHIC | ef20048898_ex99-2slide10.jpg | GRAPHIC | 131261
17 | GRAPHIC | ef20048898_ex99-2slide11.jpg | GRAPHIC | 103736
18 | GRAPHIC | ef20048898_ex99-2slide12.jpg | GRAPHIC | 122749
19 | GRAPHIC | ef20048898_ex99-2slide13.jpg | GRAPHIC | 152051
20 | GRAPHIC | ef20048898_ex99-2slide14.jpg | GRAPHIC | 115343
21 | GRAPHIC | ef20048898_ex99-2slide15.jpg | GRAPHIC | 167118
22 | GRAPHIC | ef20048898_ex99-2slide16.jpg | GRAPHIC | 201540
23 | GRAPHIC | ef20048898_ex99-2slide17.jpg | GRAPHIC | 145092
24 | GRAPHIC | ef20048898_ex99-2slide18.jpg | GRAPHIC | 146867
25 | GRAPHIC | ef20048898_ex99-2slide19.jpg | GRAPHIC | 204820
26 | GRAPHIC | ef20048898_ex99-2slide20.jpg | GRAPHIC | 160307
27 | GRAPHIC | ef20048898_ex99-2slide21.jpg | GRAPHIC | 69096
28 | GRAPHIC | ef20048898_ex99-2slide22.jpg | GRAPHIC | 121871
29 | GRAPHIC | ef20048898_ex99-2slide23.jpg | GRAPHIC | 195448
30 | GRAPHIC | ef20048898_ex99-2slide24.jpg | GRAPHIC | 137951
31 | GRAPHIC | ef20048898_ex99-2slide25.jpg | GRAPHIC | 167417
32 | GRAPHIC | ef20048898_ex99-2slide26.jpg | GRAPHIC | 173006
33 | GRAPHIC | ef20048898_ex99-2slide27.jpg | GRAPHIC | 144471
34 | GRAPHIC | ef20048898_ex99-2slide28.jpg | GRAPHIC | 66165
35 | GRAPHIC | image01.jpg | GRAPHIC | 3444
| Complete submission text file | 0001140361-25-020157.txt |  | 5949460

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | gyre-20250522.xsd | EX-101.SCH | 4024
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | gyre-20250522_lab.xml | EX-101.LAB | 21966
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | gyre-20250522_pre.xml | EX-101.PRE | 16072
46 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20048898_8k_htm.xml | XML | 4205

Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 25976969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)